PROJECT

Projects

Environmental Review Summary

Project Number

24994

Company Name

ADVANCED BIO EXTRACTS LIMITED

Date ERS Disclosed

May 16, 2006

Country

Kenya

Region

Africa

Environmental Category

B - Limited

Status

Completed

Previous Events

Approved : Jun 23, 2006
Signed : Jan 18, 2007
Invested : Mar 4, 2008

Sector

Pharmaceuticals and Medicine

Industry

other

Department

Regional Industry - MAS Africa

Project Description

Advanced Bio-Extracts Limited (ABE or the company), along with its subsidiaries, is the pioneer and leading commercial producer of artemisinin in East Africa. The company is setting up production facilities to:

- extract crude artemisinin from 6,600 TPA of Artemisia annua leaves by June 2007; and
- using the crude artemisinin to process up to 50 TPA of pure artemisinin by April 2008.

The project is estimated to cost approximately $25.0 million and includes:

- $12.4 million of capital expenditure;
- $6.5 million of preoperative expenses (including technology development); and
- $6.0 million for working capital financing.

IFC’s proposed investment will be a combination of long-term debt and quasi-equity of up to $9 million, expected to be in the form of up to $6 million in an A loan and up to $3 million of a C loan for IFC’s own account.

The company started commercial production, at a limited scale, in October 2005. Once the artemisinin production is well established, the company plans to diversify into the production of artemisinin- based derivatives and other plant-based extracts, some of which are related to the pharmaceutical industry.

Environmental and Social

Conclusion & Monitoring